Group 1 - China Metallurgical Group Corporation (China MCC) experienced a stock price increase of 5.71%, reaching 3.70 CNY per share, with a trading volume of 346 million CNY and a turnover rate of 0.54%, resulting in a total market capitalization of 76.677 billion CNY [1] - The company, established on December 1, 2008, and listed on September 21, 2009, is primarily engaged in engineering contracting (90.83% of revenue), resource development, equipment manufacturing, real estate development, and other businesses [1] Group 2 - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in China MCC, specifically the Zhejiang Huijin Quantitative Selected Stock A (011824), which held 329,600 shares in the second quarter, unchanged from the previous period, accounting for 0.77% of the fund's net value [2] - The fund has achieved a year-to-date return of 27.72%, ranking 2064 out of 4220 in its category, and a one-year return of 45.12%, ranking 1512 out of 3846 [2] Group 3 - The fund manager of Zhejiang Huijin Quantitative Selected Stock A is Chen Gujun, who has been in the position for 5 years and 255 days, with the fund's total asset size at 204 million CNY [3] - During Chen Gujun's tenure, the best fund return was 37.16%, while the worst return was -7.57% [3]

Group 1 - The core viewpoint of the news is that Yingke Medical has seen a significant increase in its stock price, rising by 5.33% to 38.76 CNY per share, with a trading volume of 444 million CNY and a turnover rate of 2.54%, resulting in a total market capitalization of 25.38 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] - The company is located in Zibo City, Shandong Province, and has its Hong Kong office at 40/F, Sunshine Center, 248 Queen's Road East, Wanchai [1] Group 2 - From the perspective of fund holdings, a fund under Zheshang Securities Asset Management has a significant position in Yingke Medical, with Zheshang Huijin Quantitative Selected Stocks A (011824) holding 40,200 shares, accounting for 0.75% of the fund's net value, making it the second-largest holding [2] - The fund has achieved a year-to-date return of 27.29%, ranking 2094 out of 4220 in its category, and a one-year return of 58.4%, ranking 1473 out of 3824 [2] - The fund manager, Chen Gujun, has been in position for 5 years and 251 days, with the fund's total asset size at 204 million CNY and a best return of 35.77% during his tenure [3]

9月22日，中国中冶跌2.08%，截至发稿，报3.30元/股，成交2.62亿元，换手率0.44%，总市值683.88亿 元。中国中冶股价已经连续4天下跌，区间累计跌幅5.44%。 资料显示，中国冶金科工股份有限公司位于北京市朝阳区曙光西里28号中冶大厦，成立日期2008年12月 1日，上市日期2009年9月21日，公司主营业务涉及工程承包、资源开发、装备制造、房地产开发及其他 业务。主营业务收入构成为：工程承包90.83%，特色业务7.10%，综合地产2.02%，其他0.05%。 从基金十大重仓股角度 数据显示，浙商证券资管旗下1只基金重仓中国中冶。浙商汇金量化臻选股票A（011824）二季度持有 股数32.96万股，与上期相比持股数量不变，占基金净值比例为0.77%，位居第一大重仓股。根据测算， 今日浮亏损失约2.31万元。连续4天下跌期间浮亏损失6.26万元。 浙商汇金量化臻选股票A（011824）成立日期2021年7月1日，最新规模6380.8万。今年以来收益 26.45%，同类排名1864/4222；近一年收益64.64%，同类排名1356/3813；成立以来收益16.3%。 浙商汇金量化臻选股票A（ ...

截至发稿，陈顾君累计任职时间5年229天，现任基金资产总规模2.04亿元，任职期间最佳基金回报 33.77%， 任职期间最差基金回报-7.57%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，浙商证券资管旗下1只基金重仓建龙微纳。浙商汇金量化臻选股票A（011824）二季度持有 股数3.22万股，占基金净值比例为0.73%，位居第八大重仓股。根据测算，今日浮盈赚取约5.53万元。 浙商汇金量化臻选股票A（011824）成立日期2021年7月1日，最新规模6380.8万。今年以来收益 23.52%，同类排名1698/4222；近一年收益58.88%，同类排名1287/3789；成立以来收益13.6%。 浙商汇金量化臻选股票A（011824）基金经理为陈顾君。 9月4日，建龙微纳涨5.31%，截至发稿，报34.14元/股，成交2188.93万元，换手率0.65%，总市值34.16 亿元。 资料显示，洛阳建龙微纳新材料股份有限公司位于河南省洛阳 ...